Mr. Mahendra Patel, MD, Lincoln Pharmaceuticals Ltd Business Highlights:- Total Income in Q1FY23 at Rs. 129.97 crore, up 24.4% from Rs. 104.4 crore in Q4FY22 Commercial operations of Cephalosporin Plant and Export to EU & Australia to commence in FY23 Company continuous to remain ‘Net Debt Free’ after multiple expansion & acquisition of Cephalosporin plant…
| Powered by WordPress | Theme by TheBootstrapThemes